Nordea Investment Management AB Has $353.80 Million Position in Cigna Group $CI

Nordea Investment Management AB decreased its position in Cigna Group (NYSE:CIFree Report) by 12.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,277,393 shares of the health services provider’s stock after selling 180,829 shares during the quarter. Nordea Investment Management AB’s holdings in Cigna Group were worth $353,800,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Dodge & Cox lifted its position in Cigna Group by 4.0% during the 3rd quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock worth $2,682,231,000 after buying an additional 354,615 shares in the last quarter. Sanders Capital LLC increased its position in Cigna Group by 0.5% in the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock worth $2,256,469,000 after purchasing an additional 35,150 shares during the period. Norges Bank acquired a new stake in Cigna Group in the second quarter worth about $1,110,426,000. Capital Research Global Investors raised its holdings in Cigna Group by 140.2% during the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after purchasing an additional 1,855,897 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its position in Cigna Group by 7.4% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,695,620 shares of the health services provider’s stock valued at $777,012,000 after purchasing an additional 186,880 shares during the period. 86.99% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

CI has been the subject of several analyst reports. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Piper Sandler reduced their price objective on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Barclays dropped their price target on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a research report on Friday, February 6th. Finally, Mizuho set a $325.00 price objective on Cigna Group in a report on Friday, January 9th. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $333.11.

Check Out Our Latest Report on CI

Insider Transactions at Cigna Group

In other news, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their position. The SEC filing for this sale provides additional information. 0.70% of the stock is currently owned by corporate insiders.

Cigna Group Price Performance

NYSE:CI opened at $262.83 on Friday. The firm’s fifty day moving average price is $277.86 and its two-hundred day moving average price is $281.57. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. The company has a market cap of $69.26 billion, a P/E ratio of 11.85, a P/E/G ratio of 0.91 and a beta of 0.27. Cigna Group has a one year low of $239.51 and a one year high of $350.00.

Cigna Group (NYSE:CIGet Free Report) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The company had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company’s revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the firm earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities analysts expect that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th were paid a dividend of $1.56 per share. The ex-dividend date of this dividend was Thursday, March 5th. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 annualized dividend and a yield of 2.4%. Cigna Group’s payout ratio is presently 28.13%.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.